|
ATE261724T1
(de)
|
1998-11-17 |
2004-04-15 |
Ortho Mcneil Pharm Inc |
Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
|
|
AU1909700A
(en)
*
|
1998-12-03 |
2000-06-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Topiramate and related derivatives for treating Schizophrenia
|
|
US6552000B2
(en)
|
1999-02-08 |
2003-04-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in treating autism
|
|
NZ513643A
(en)
|
1999-02-24 |
2005-04-29 |
Univ Cincinnati |
Use of sulfamate derivatives for treating impulse control disorders
|
|
US6583172B1
(en)
|
1999-04-08 |
2003-06-24 |
Richard P. Shank |
Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
|
|
US6420369B1
(en)
|
1999-05-24 |
2002-07-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in treating dementia
|
|
US7553818B2
(en)
*
|
1999-06-14 |
2009-06-30 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US20080255093A1
(en)
*
|
1999-06-14 |
2008-10-16 |
Tam Peter Y |
Compositions and methods for treating obesity and related disorders
|
|
US20080103179A1
(en)
*
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
WO2000076493A1
(en)
|
1999-06-14 |
2000-12-21 |
Thomas Najarian |
Combination therapy for effecting weight loss and treating obesity
|
|
US7659256B2
(en)
*
|
1999-06-14 |
2010-02-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US7674776B2
(en)
|
1999-06-14 |
2010-03-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US7056890B2
(en)
|
1999-06-14 |
2006-06-06 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
|
US6191117B1
(en)
*
|
2000-07-10 |
2001-02-20 |
Walter E. Kozachuk |
Methods of producing weight loss and treatment of obesity
|
|
CA2417304A1
(en)
*
|
2000-08-02 |
2002-02-07 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful for the treatment of depression
|
|
AU2002227052A1
(en)
|
2000-11-30 |
2002-06-11 |
University Of Florida |
Treatments for neurogenetic disorders, impulse control disorders, and wound healing
|
|
US7041650B2
(en)
*
|
2001-07-09 |
2006-05-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivative salts
|
|
CA2459146A1
(en)
*
|
2001-08-30 |
2003-03-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
|
|
US20040235957A1
(en)
*
|
2001-10-12 |
2004-11-25 |
David Bleakman |
Use of sulfonamide derivatives as pharmaceuticals compounds
|
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
|
US6559293B1
(en)
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
|
IL163846A0
(en)
*
|
2002-03-01 |
2005-12-18 |
Univ South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
IL165383A0
(en)
*
|
2002-06-21 |
2006-01-15 |
Transform Pharmaceuticals Inc |
Pharmaceutical compositions with improved dissolution
|
|
EP1534238A1
(en)
*
|
2002-07-29 |
2005-06-01 |
ALZA Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
|
US7196209B2
(en)
*
|
2002-10-31 |
2007-03-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Continuous process for the preparation of fructopyranose sulfamate derivatives
|
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
|
US20050070524A1
(en)
*
|
2003-06-06 |
2005-03-31 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
|
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
|
AR049646A1
(es)
*
|
2004-06-16 |
2006-08-23 |
Janssen Pharmaceutica Nv |
Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
|
|
MY147767A
(en)
*
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
JP4912312B2
(ja)
*
|
2004-08-24 |
2012-04-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗痙攣薬として有用な新規なベンゾ−縮合ヘテロアリールスルファミド誘導体
|
|
CA2609185A1
(en)
*
|
2005-05-20 |
2006-11-30 |
Ahmed F. Abdel-Magid |
Process for preparation of sulfamide derivatives
|
|
US8937096B2
(en)
*
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
|
US20070155827A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
|
|
US8716231B2
(en)
*
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
|
US8691867B2
(en)
*
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
|
US8497298B2
(en)
*
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
|
US8492431B2
(en)
*
|
2005-12-19 |
2013-07-23 |
Janssen Pharmaceutica, N.V. |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
|
|
US20070155823A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
|
|
US20070191450A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder
|
|
US20070191449A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
|
|
US20070191474A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
|
|
AU2007253814A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Janssen Pharmaceutica N.V. |
Co-therapy for the treatment of epilepsy
|
|
WO2008027557A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Spherics, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
|
EP2394643B1
(en)
|
2006-11-17 |
2015-09-02 |
Supernus Pharmaceuticals, Inc. |
Sustained-release formulations of topiramate
|
|
EP2363113B1
(en)
|
2006-12-04 |
2017-08-02 |
Supernus Pharmaceuticals, Inc. |
Enhanced immediate release formulations of topiramate
|
|
US20090247616A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
|
|
US20090247617A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Abdel-Magid Ahmed F |
Process for the preparation of benzo-fused heteroaryl sulfamates
|
|
US8580298B2
(en)
*
|
2008-06-09 |
2013-11-12 |
Vivus, Inc. |
Low dose topiramate/phentermine composition and methods of use thereof
|
|
US20090304789A1
(en)
*
|
2008-06-09 |
2009-12-10 |
Thomas Najarian |
Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
|
|
WO2010008776A2
(en)
|
2008-06-23 |
2010-01-21 |
Janssen Pharmaceutica Nv |
Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
|
|
US8815939B2
(en)
*
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
|
US8652527B1
(en)
|
2013-03-13 |
2014-02-18 |
Upsher-Smith Laboratories, Inc |
Extended-release topiramate capsules
|
|
US9101545B2
(en)
|
2013-03-15 |
2015-08-11 |
Upsher-Smith Laboratories, Inc. |
Extended-release topiramate capsules
|
|
WO2020104837A1
(en)
|
2018-11-21 |
2020-05-28 |
Rosemont Pharmaceuticals Limited |
Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
|